APPLIED PATHOPHYSIOLOGY FOR THE ADVANCED NURSE STUDY
SOLVED QUESTIONS WITH CORRECT ANSWERS
◉ platelet plug. Answer: The initial step in hemostasis where
platelets adhere to a damaged vessel.
◉ adhesion. Answer: The process by which platelets stick to the
damaged vessel to form a plug.
◉ blood coagulation. Answer: A process initiated by intrinsic or
extrinsic pathways leading to clot formation.
◉ factor XII. Answer: A component required in the intrinsic pathway
of blood coagulation.
◉ hypercoagulability. Answer: A condition characterized by
increased platelet function.
◉ Immune thrombocytopenia purpura (ITP). Answer: An
autoimmune disorder that destroys platelets.
,◉ Thrombotic thrombocytopenic purpura (TTP). Answer: A
condition that causes manifestations such as purpura, jaundice,
petechiae, and confusion.
◉ Hemophilia A. Answer: A hereditary blood disorder caused by
inadequate activity or absent factor VIII.
◉ Disseminated intravascular coagulation (DIC). Answer: A
condition characterized by hemorrhage and platelet loss.
◉ vascular defects. Answer: Conditions that may cause bleeding
disorders, often revealing normal laboratory test values.
◉ hypocalcemia. Answer: A condition characterized by low levels of
calcium in the blood.
◉ polycythemia. Answer: A disorder characterized by an increased
number of red blood cells.
◉ thrombocytopenia. Answer: A condition in which there is a lower
than normal number of platelets in the blood.
,◉ platelet plug formation. Answer: The process that occurs during
hemostasis where platelets adhere to the site of a blood vessel
injury.
◉ von Willebrand factor. Answer: A blood glycoprotein involved in
hemostasis that helps platelets adhere to the blood vessel wall.
◉ prothrombin to thrombin conversion. Answer: The process in
which prothrombin is converted into thrombin, an enzyme that
plays a key role in blood coagulation.
◉ fibrinogen to fibrin conversion. Answer: The transformation of
fibrinogen, a soluble plasma protein, into fibrin, which forms a mesh
that stabilizes the platelet plug.
◉ clopidogrel (Plavix). Answer: A medication that prevents platelet
aggregation, thereby reducing the risk of blood clots.
◉ hypercoagulability disorders. Answer: Conditions that increase
the likelihood of blood clot formation.
◉ smoking cessation. Answer: The process of discontinuing tobacco
smoking, which can reduce the risk of hypercoagulability.
, ◉ weight management. Answer: The process of adopting a healthy
lifestyle to maintain a healthy body weight, which can influence
hypercoagulability risk.
◉ cholesterol screening and management. Answer: The assessment
and control of cholesterol levels to prevent cardiovascular diseases.
◉ blood pressure screening and management. Answer: The
monitoring and control of blood pressure to reduce health risks.
◉ Leiden mutation. Answer: A genetic mutation that increases the
risk of developing blood clots, particularly deep vein thrombosis.
◉ deep vein thrombosis. Answer: A condition where a blood clot
forms in a deep vein, usually in the legs.
◉ acute myelogenous leukemia (AML). Answer: A type of cancer that
affects the blood and bone marrow, leading to the production of
abnormal white blood cells.
◉ abnormal bleeding. Answer: Unusual bleeding that can occur in
various parts of the body due to low platelet counts.
SOLVED QUESTIONS WITH CORRECT ANSWERS
◉ platelet plug. Answer: The initial step in hemostasis where
platelets adhere to a damaged vessel.
◉ adhesion. Answer: The process by which platelets stick to the
damaged vessel to form a plug.
◉ blood coagulation. Answer: A process initiated by intrinsic or
extrinsic pathways leading to clot formation.
◉ factor XII. Answer: A component required in the intrinsic pathway
of blood coagulation.
◉ hypercoagulability. Answer: A condition characterized by
increased platelet function.
◉ Immune thrombocytopenia purpura (ITP). Answer: An
autoimmune disorder that destroys platelets.
,◉ Thrombotic thrombocytopenic purpura (TTP). Answer: A
condition that causes manifestations such as purpura, jaundice,
petechiae, and confusion.
◉ Hemophilia A. Answer: A hereditary blood disorder caused by
inadequate activity or absent factor VIII.
◉ Disseminated intravascular coagulation (DIC). Answer: A
condition characterized by hemorrhage and platelet loss.
◉ vascular defects. Answer: Conditions that may cause bleeding
disorders, often revealing normal laboratory test values.
◉ hypocalcemia. Answer: A condition characterized by low levels of
calcium in the blood.
◉ polycythemia. Answer: A disorder characterized by an increased
number of red blood cells.
◉ thrombocytopenia. Answer: A condition in which there is a lower
than normal number of platelets in the blood.
,◉ platelet plug formation. Answer: The process that occurs during
hemostasis where platelets adhere to the site of a blood vessel
injury.
◉ von Willebrand factor. Answer: A blood glycoprotein involved in
hemostasis that helps platelets adhere to the blood vessel wall.
◉ prothrombin to thrombin conversion. Answer: The process in
which prothrombin is converted into thrombin, an enzyme that
plays a key role in blood coagulation.
◉ fibrinogen to fibrin conversion. Answer: The transformation of
fibrinogen, a soluble plasma protein, into fibrin, which forms a mesh
that stabilizes the platelet plug.
◉ clopidogrel (Plavix). Answer: A medication that prevents platelet
aggregation, thereby reducing the risk of blood clots.
◉ hypercoagulability disorders. Answer: Conditions that increase
the likelihood of blood clot formation.
◉ smoking cessation. Answer: The process of discontinuing tobacco
smoking, which can reduce the risk of hypercoagulability.
, ◉ weight management. Answer: The process of adopting a healthy
lifestyle to maintain a healthy body weight, which can influence
hypercoagulability risk.
◉ cholesterol screening and management. Answer: The assessment
and control of cholesterol levels to prevent cardiovascular diseases.
◉ blood pressure screening and management. Answer: The
monitoring and control of blood pressure to reduce health risks.
◉ Leiden mutation. Answer: A genetic mutation that increases the
risk of developing blood clots, particularly deep vein thrombosis.
◉ deep vein thrombosis. Answer: A condition where a blood clot
forms in a deep vein, usually in the legs.
◉ acute myelogenous leukemia (AML). Answer: A type of cancer that
affects the blood and bone marrow, leading to the production of
abnormal white blood cells.
◉ abnormal bleeding. Answer: Unusual bleeding that can occur in
various parts of the body due to low platelet counts.
